DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
CAM2038 is an investigational drug.
There have been 10 clinical trials for CAM2038. The most recent clinical trial was a Phase 3 trial, which was initiated on October 1st 2020.
The most common disease conditions in clinical trials are Disease, Substance-Related Disorders, and Substance Withdrawal Syndrome. The leading clinical trial sponsors are Braeburn Pharmaceuticals, National Institute on Drug Abuse (NIDA), and Theresa Winhusen, PhD.
There are six hundred and nine US patents protecting this investigational drug and eight international patents.
Recent Clinical Trials for CAM2038
|Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-study||National Institute on Drug Abuse (NIDA)||Phase 3|
|Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-study||The EMMES Corporation||Phase 3|
|Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-study||Theresa Winhusen, PhD||Phase 3|
Top disease conditions for CAM2038
Top clinical trial sponsors for CAM2038
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|CAM2038||Start Trial||Ethylsulfonated hyaluronic acid biopolymers and methods of use thereof||The Regents of the University of California (Oakland, CA)||Start Trial|
|CAM2038||Start Trial||Tactile sensing device for lumbar punctures||TEXAS MEDICAL CENTER (Houston, TX)||Start Trial|
|CAM2038||Start Trial||Methods and devices to reduce damaging effects of concussive or blast forces on a subject||TBI INNOVATIONS, LLC (Richmond, IN) THORNHILL RESEARCH, INC. (Toronto, Ontario, CA)||Start Trial|
|CAM2038||Start Trial||Pharmaceutical formulations||GW Pharma Limited (Cambridge, GB)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|CAM2038||European Patent Office||EP2981556||2033-04-02||Start Trial|
|CAM2038||World Intellectual Property Organization (WIPO)||WO2014165513||2033-04-02||Start Trial|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|